Short term health-related quality-of-life in men with metastatic castration-resistant prostate cancer treated with first-line enzalutamide or abiraterone plus prednisone: a systematic review and meta-analysis

Klara Kvorning Ternov, AB Nolsøe, O Bratt, Mikkel Fode , H Lindberg, C Kistorp, G Palapattu, TW Klausen, Jens Otto Reimers Sønksen, Peter Busch Østergren

OriginalsprogEngelsk
Publikationsdato2019
StatusUdgivet - 2019

Citationsformater